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BSTRACT
 
Background
 
It is uncertain whether male circum-
cision reduces the risks of penile human papillomavi-
rus (HPV) infection in the man and of cervical cancer
in his female partner.
 
Methods
 
We pooled data on 1913 couples enrolled
in one of seven case–control studies of cervical carci-
noma in situ and cervical cancer in five countries. Cir-
cumcision status was self-reported, and the accuracy
of the data was confirmed by physical examination at
three study sites. The presence or absence of penile
HPV DNA was assessed by a polymerase-chain-reac-
tion assay in 1520 men and yielded a valid result in the
case of 1139 men (74.9 percent).
 
Results
 
Penile HPV was detected in 166 of the 847
uncircumcised men (19.6 percent) and in 16 of the 292
circumcised men (5.5 percent). After adjustment for
age at first intercourse, lifetime number of sexual part-
ners, and other potential confounders, circumcised
men were less likely than uncircumcised men to have
HPV infection (odds ratio, 0.37; 95 percent confidence
interval, 0.16 to 0.85). Monogamous women whose
male partners had six or more sexual partners and
were circumcised had a lower risk of cervical cancer
than women whose partners were uncircumcised (ad-
justed odds ratio, 0.42; 95 percent confidence interval,
0.23 to 0.79). Results were similar in the subgroup of
men in whom circumcision was confirmed by medi-
cal examination.
 
Conclusions
 
Male circumcision is associated with
a reduced risk of penile HPV infection and, in the case
of men with a history of multiple sexual partners, a
reduced risk of cervical cancer in their current female
partners. (N Engl J Med 2002;346:1105-12.)
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INCE Hutchinson reported in 1855 that cir-
cumcision might prevent syphilis,
 
1
 
 studies have
suggested that circumcision may reduce the
risk of penile cancer, urinary tract infections,
and common sexually transmitted diseases, including
human immunodeficiency virus (HIV) infection.
 
2-9
 
Little is known, however, about the effect of male cir-
cumcision on the risk of acquiring human papilloma-
virus (HPV). HPV causes genital warts in men and
women, and it has been linked to cancers of the cer-
vix, vulva, vagina, anus, and penis.
 
10,11
 
 Cervical cancer
is the second most common cancer among women
worldwide, and up to 99 percent of all cases may be
attributed to infection by oncogenic HPV geno-
types.
 
12,13
 
 Therefore, factors that reduce the proba-
bility of acquiring or transmitting HPV among men
or women may reduce the risk of disease associated
with these infections.
During the past 15 years the International Agency
for Research on Cancer has performed several large
case–control studies of cervical cancer in different
countries. We used data from these studies to assess
the effect of male circumcision on the risk of genital
HPV infection in the men themselves and the risk of
cervical cancer in their sexual partners.
S
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METHODS
 
Study Design
 
Study subjects were enrolled in one of seven case–control studies,
five involving invasive cervical cancer and two involving cervical car-
cinoma in situ. The fieldwork for these studies was conducted from
1985 through 1993. Two studies each were conducted in Spain and
Colombia, and one study each was conducted in Brazil, Thailand,
and the Philippines. Details of the methods of each study, as well as
the results of analyses of some risk factors for cervical cancer, have
been published previously.
 
14-23
 
 Female patients were women who
had newly diagnosed, histologically confirmed cervical carcinoma
in situ or invasive cervical cancer. Control women were recruited
from the general population in the two studies of invasive cervical
cancer in Spain and Colombia (population-based studies) and from
the same hospitals as the patients in the case of the other studies
(hospital-based studies). In all studies, control women were frequen-
cy-matched to the women with cervical cancer according to age.
Since male and female risk factors for carcinoma in situ were sim-
ilar to those for invasive cervical cancer, women with carcinoma in
situ and controls were also included in the present analysis.
 
24
 
Men who were eligible for the present study were the husbands
or stable partners of the women with cervical cancer and the con-
trol women enrolled in each of these studies. A man was considered
to be a stable partner of an enrolled woman if he reported having
had regular sexual intercourse with the woman for at least six
months, whether or not they were married or lived together.
All protocols were approved by the International Agency for Re-
search on Cancer and the local ethics and research committees.
Informed consent was obtained from all study subjects. Oral con-
sent was obtained from the subjects in the Spanish and Colombian
studies (which were initiated in 1985), consistent with the standard
at the time. In the remaining studies, which were initiated later,
written informed consent was obtained.
 
Questionnaire and Medical Examination
 
Subjects were interviewed with use of a standardized question-
naire administered in person by specially trained interviewers. De-
tailed information was collected on demographic and socioeconom-
ic variables, sexual history, and circumcision status.
The circumcision status was assessed by a clinician in the case of
794 of the 815 men (97.4 percent) who were recruited in the studies
in Brazil, Thailand, and the Philippines. After the exclusion of 4 men
whose circumcision status was assessed as uncertain by the clinician,
medical examination of the penis confirmed the self-reported cir-
cumcision status in 748 of 790 of the male partners (94.7 percent).
Only 1.7 percent of men (5 of 287) who reported having been cir-
cumcised were considered by the clinician to be uncircumcised, and
7.4 percent of men (37 of 503) who reported not having been cir-
cumcised were considered by the clinician as having been circum-
cised (kappa, 0.89). On the basis of this high degree of reliability,
the self-reported circumcision status was used for all analyses.
 
Detection of HPV DNA
 
Two samples of exfoliated cells were obtained from the penis:
one from the distal urethra with the use of a very thin, wet, cotton-
tipped swab and one from the external surface of the glans and coro-
nal sulcus with the use of a standard-sized wet, cotton-tipped swab.
Cervical exfoliated cells were collected from the women as previous-
ly described.
 
14-20
 
 The detailed protocol used for the polymerase-
chain-reaction (PCR) assay for the detection of HPV DNA in the
cervical and penile specimens has been described previously.
 
14-23
 
Briefly, the L1 consensus primers MY09–MY11, as modified by
Hildesheim et al.,
 
25
 
 were used for the samples collected in the Co-
lombian and Spanish studies. The GP5+/6+ general primer sys-
tem was used for the samples collected in the remaining studies.
PCR products were assessed for HPV DNA with the use of a cock-
tail of HPV-specific probes and were genotyped by hybridization
of the PCR products with type-specific probes for 33 HPV types
in the case of cervical samples and for at least 6 HPV types (6, 11,
16, 18, 31, and 33) in the case of penile samples.
 
26,27
 
 Samples that
were positive for HPV but that did not hybridize with any of the
type-specific probes were called “HPV X.” Amplification of a frag-
ment of the 
 
b
 
-globin gene served as an internal quality control for
each specimen.
 
Statistical Analysis
 
We used unconditional logistic regression to estimate odds ratios
and 95 percent confidence intervals in order to measure associations
between specific variables and the risk of penile HPV infection or
cervical cancer. All logistic-regression models were adjusted for the
age of the male partner (in quartiles) and the study in which his
partner was enrolled (seven categories). Covariables in the model
for penile HPV infection included the male partner’s level of edu-
cation (primary school or less vs. secondary school or higher), the
age at which he first had sexual intercourse («16, 17 to 18, or »19
years), his lifetime number of sexual partners (1 to 5, 6 to 20, or
»21), and his self-reported frequency of genital washing after inter-
course (always vs. occasionally or never). The Wald test, adjusted for
the same covariables, was used to assess the association of each var-
iable with circumcision status. Further adjustment for case–control
status or the presence of cervical HPV DNA did not substantially
alter the point estimates, and these variables were not included in
the analyses. Logistic-regression models for cervical cancer were also
adjusted for the woman’s age, her lifetime number of sexual part-
ners, and the age at which she first had sexual intercourse. Fisher’s
exact test was used to assess the association between male circum-
cision status and the risk of penile HPV infection, with stratification
according to several characteristics of the men.
We assessed whether the association of circumcision status with
the risk of penile HPV infection and cervical cancer differed signif-
icantly according to the country in which the various studies were
conducted by including in the fully adjusted logistic-regression
model an interaction term combining country and circumcision
status. A two-sided P value of less than 0.05 was considered to in-
dicate statistical significance.
 
RESULTS
 
Study Subjects
 
Of the 3790 women (1896 women with cervical
cancer and 1894 controls) who were enrolled in the
seven case–control studies, 2800 (1329 women with
cervical cancer and 1471 controls) reported having a
husband or stable male partner at study entry. A total
of 984 of the 1329 partners of women with cervical
cancer (74.0 percent) and 937 of the 1471 partners of
control women (63.7 percent) were interviewed. Of
these, 807 partners of patients (82.0 percent of those
interviewed) and 717 partners of control women (76.5
percent) provided cytologic specimens, of which 610
(75.6 percent) and 533 (74.3 percent), respectively,
yielded a valid PCR result. Eight men whose circum-
cision status was unknown (four with a valid PCR re-
sult and four who did not provide samples) were ex-
cluded from the analyses.
Overall, the men whose HPV status could be con-
firmed by PCR assay were similar to the men whose
HPV status could not be established with respect to
age, level of education, circumcision status, and var-
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iables related to sexual behavior. In Colombia, highly
educated men were more likely than less educated men
to have a valid PCR result. In Thailand, uncircumcised
men and men who reported having had a large num-
ber of sexual partners were more likely to have a valid
PCR result than their counterparts. However, the ex-
clusion of men from Thailand did not substantially al-
ter the magnitude of the associations.
Women whose partners participated in the study did
not differ significantly from women whose partners
did not participate with respect to age, level of educa-
tion, or variables related to sexual behavior. Likewise,
women whose partners were tested for HPV infection
were similar to those whose partners were not tested.
 
Characteristics of the Subjects
 
The overall prevalence of self-reported circumcision
was 19.3 percent (370 of 1913 men): 1.5 percent in
Colombia, 6.1 percent in Brazil, 10.0 percent in Thai-
land, 11.5 percent in Spain, and 91.0 percent in the
Philippines. As compared with uncircumcised men,
circumcised men had a higher level of education, were
less likely to report frequent genital washing after sex,
and were more likely to have good genital hygiene, as
assessed by a physician (Table 1).
 
Circumcision and Penile HPV Infection
 
HPV DNA was detected in 182 of the 1139 penile
specimens (16.0 percent). The most common HPV
genotypes were 16 (24.7 percent of all positive sam-
ples), 18 (4.9 percent), 6 or 11 (3.3 percent), 53 (3.3
percent), 31 (2.7 percent), and 33 (2.2 percent). The
type could not be identified in the case of 51.1 per-
cent of the positive samples. HPV types 35, 39, 45,
51, 52, 54, and 59 each accounted for less than 1.5
percent of the positive samples.
HPV was detected in 19.6 percent of uncircumcised
men (166 of 847) and 5.5 percent of circumcised men
(16 of 292). As compared with uncircumcised men,
circumcised men had a lower prevalence of HPV in-
fection in all subgroups defined according to base-line
characteristics (Table 2).
The overall odds ratio for penile HPV infection as-
sociated with self-reported circumcision was 0.37 (95
percent confidence interval, 0.16 to 0.85), after adjust-
ment for age, study location, level of education, age at
first sexual intercourse, lifetime number of sexual part-
ners, and frequency of genital washing after sex. The
adjusted odds ratio associated with clinician-assessed
circumcision was 0.44 (95 percent confidence inter-
val, 0.17 to 1.13). There was an inverse association be-
tween circumcision and the risk of HPV infection in
all studies (P for heterogeneity=0.87), and this find-
ing persisted whether or not the female partner had
cervical HPV infection or had been given a diagnosis
of cervical cancer (data not shown). The only other
 
*Because of rounding, percentages may not total 100.
†Wald’s test was used to assess the association between each character-
istic and circumcision status, adjusted for study location, age, level of edu-
cation, age at first sexual intercourse, lifetime number of sexual partners,
and frequency of genital washing after sex.
‡Subjects from Colombia and Spain were excluded.
§The analysis is limited to men who had had sex with prostitutes.
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no. (%)
 
Study location
Brazil
Colombia
Thailand
Philippines
Spain
139 (9.0)
464 (30.1)
361 (23.4)
24 (1.6)
555 (36.0)
9 (2.4)
7 (1.9)
40 (10.8)
242 (65.4)
72 (19.5)
<0.001
Age
«37 yr
38–46 yr
47–56 yr
»57 yr
399 (25.9)
363 (23.5)
381 (24.7)
400 (25.9)
97 (26.2)
102 (27.6)
89 (24.0)
82 (22.2)
0.43
Level of education
Never attended school
Primary school
Secondary school or higher
Unknown
179 (11.6)
862 (55.9)
499 (32.3)
3 (0.2)
8 (2.2)
123 (33.2)
239 (64.6)
0
0.06
Age at first sexual intercourse
«16 yr
17–18 yr
»19 yr
Unknown
573 (37.1)
408 (26.4)
560 (36.3)
2 (0.1)
65 (17.6)
84 (22.7)
221 (59.7)
0
0.14
Lifetime number of sexual partners
1–5
6–20
»21
Unknown
490 (31.8)
483 (31.3)
548 (35.5)
22 (1.4)
183 (49.5)
115 (31.1)
69 (18.6)
3 (0.8)
0.52
Sexual intercourse with prostitutes
No
Yes
Unknown
488 (31.6)
1049 (68.0)
6 (0.4)
174 (47.0)
196 (53.0)
0
0.99
Genital washing after intercourse
Always
Never or occasionally
Unknown
625 (40.5)
916 (59.4)
2 (0.1)
85 (23.0)
285 (77.0)
0
<0.05
Physician’s assessment of genital 
hygiene‡
Good
Fair or poor
Unknown
281 (53.6)
224 (42.7)
19 (3.6)
207 (71.1)
80 (27.5)
4 (1.4)
<0.001
Condom use with regular partner‡
No
Yes
Unknown
462 (88.2)
62 (11.8)
0
207 (71.1)
83 (28.5)
1 (0.3)
0.36
Condom use with prostitutes§
Never or occasionally
Usually or always
Unknown
709 (67.6)
337 (32.1)
3 (0.3)
61 (31.1)
134 (68.4)
1 (0.5)
0.29
Current partner’s lifetime number
of sexual partners
1
2–3
»4
Unknown
1118 (72.5)
376 (24.4)
48 (3.1)
      1 (<0.1)
302 (81.6)
58 (15.7)
10 (2.7)
0
0.84
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*Because of rounding, percentages may not total 100.
†Fisher’s exact test was used to assess the association between penile HPV and circumcision status.
‡Subjects from Colombia and Spain were excluded.
§The analysis is limited to men who had had sex with prostitutes.
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†
 
NO
 
.
 
TESTED
NO
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POSITIVE
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 HPV (%)
 
NO
 
.
 
TESTED
NO
 
. POSITIVE
FOR HPV (%)
Overall 847 166 (19.6) 292 16 (5.5) <0.001
Study location
Brazil 103 40 (38.8) 6 1 (16.7) 0.41
Colombia 236 52 (22.0) 4 0 0.58
Thailand 171 35 (20.5) 12 2 (16.7) 1.0
Philippines 22 2 (9.1) 233 12 (5.2) 0.34
Spain 315 37 (11.7) 37 1 (2.7) 0.16
Age
«37 yr 225 42 (18.7) 69 4 (5.8) 0.008
38–46 yr 212 39 (18.4) 88 6 (6.8) 0.01
47–56 yr 200 38 (19.0) 69 4 (5.8) 0.007
»57 yr 210 47 (22.4) 66 2 (3.0) <0.001
Level of education
Never attended school 104 21 (20.2) 3 0 
Primary school 449 87 (19.4) 88 2 (2.3) <0.001
Secondary school or higher 293 57 (19.5) 201 14 (7.0) <0.001
Unknown 1 1 (100.0) 0 0 
Age at first sexual intercourse
«16 yr 315 72 (22.9) 48 2 (4.2) 0.002
17–18 yr 229 43 (18.8) 69 5 (7.2) 0.02
»19 yr 301 51 (16.9) 175 9 (5.1) <0.001
Unknown 2 0 0 0 
Lifetime number of sexual partners
1–5 263 33 (12.5) 145 4 (2.8) 0.001
6–20 275 49 (17.8) 93 9 (9.7) 0.07
»21 301 81 (26.9) 52 3 (5.8) <0.001
Unknown 8 3 (37.5) 2 0 
Sexual intercourse with prostitutes
No 274 49 (17.9) 138 4 (2.9) <0.001
Yes 570 116 (20.4) 154 12 (7.8) <0.001
Unknown 3 1 (33.3) 0 0 
Genital washing after intercourse
Always 342 64 (18.7) 39 5 (12.8) 0.51
Never or occasionally 504 101 (20.0) 253 11 (4.3) <0.001
Unknown 1 1 (100.0) 0 0 
Physician’s assessment of genital hygiene‡
Good 160 38 (23.8) 175 13 (7.4) <0.001
Fair or poor 133 37 (27.8) 76 2 (2.6) <0.001
Unknown 3 2 (66.7) 0 0 
Condom use with regular partner‡
No 255 64 (25.1) 173 10 (5.8) <0.001
Yes 41 13 (31.7) 77 5 (6.5) 0.001
Unknown 0 0 1 0 
Condom use with prostitutes§
Never or occasionally 380 65 (17.1) 33 4 (12.1) 0.63
Usually or always 189 51 (27.0) 120 8 (6.7) <0.001
Unknown 1 0 1 0 
Current partner’s lifetime number of sexual 
partners
1 611 105 (17.2) 241 13 (5.4) <0.001
2–3 207 53 (25.6) 44 3 (6.8) 0.005
»4 28 8 (28.6) 7 0 0.17
Unknown 1 0 0 0 
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risk factor that was significantly associated with the
risk of penile HPV infection was the number of sexual
partners the men had had; as compared with men who
had five or fewer partners, those who had had six or
more partners had an odds ratio of 2.0 (95 percent
confidence interval, 1.3 to 3.2).
The odds ratio for HPV infection among circum-
cised men, as compared with uncircumcised men, was
similar after the exclusion of men from Spain and Co-
lombia; these men did not undergo a medical exami-
nation of the penis (odds ratio, 0.56; 95 percent con-
fidence interval, 0.20 to 1.56). The odds ratio was also
not changed significantly by the exclusion of men from
the Philippines, who represented 65.4 percent of all
circumcised men in the study (odds ratio, 0.32; 95
percent confidence interval, 0.11 to 0.93).
Circumcision and Cervical Cancer
Male circumcision was associated with a moderate,
but nonsignificant, decrease in the risk of cervical can-
cer in the men’s female partners (odds ratio for self-
reported circumcision, 0.72; 95 percent confidence
interval, 0.49 to 1.04; odds ratio for clinician-con-
firmed circumcision, 0.69; 95 percent confidence in-
terval, 0.43 to 1.11). There was no evidence of heter-
ogeneity with respect to the location of the study
(P=0.41), and the inverse association was not substan-
tially altered by any of the characteristics of the wom-
*In this analysis, the men’s self-reported circumcision status was used. For all analyses the reference
group is current stable female partners of uncircumcised men within the stratum. Models were ad-
justed for the study location, age of male and female subjects, male subjects’ level of education, male
subjects’ age at first sexual intercourse, male subjects’ frequency of genital washing after sex, male
subjects’ lifetime number of sexual partners, female subjects’ lifetime number of sexual partners, and
female subjects’ age at first intercourse. None of the interaction terms between risk factors and cir-
cumcision status were statistically significant. CI denotes confidence interval.
†P for heterogeneity=0.41.
TABLE 3. RISK OF CERVICAL CANCER IN FEMALE PARTNERS OF CIRCUMCISED MEN, 
AS COMPARED WITH THOSE OF UNCIRCUMCISED MEN, 
ACCORDING TO SELECTED CHARACTERISTICS OF THE WOMEN.
CHARACTERISTICS 
OF THE WOMEN
WOMEN WITH 
CERVICAL CANCER CONTROL WOMEN
ODDS RATIO
(95% CI)*
CIRCUMCISED 
PARTNER
UNCIR-
CUMCISED
PARTNER
CIRCUMCISED
PARTNER
UNCIR-
CUMCISED
PARTNER
Overall 194 783 176 760 0.72 (0.49–1.04)
Study location†
Brazil 3 69 6 70 0.41 (0.08–2.08)
Colombia 1 217 6 247 0.32 (0.04–2.88)
Thailand 22 205 18 156 1.04 (0.51–2.12)
Philippines 139 16 103 8 0.60 (0.22–1.65)
Spain 29 276 43 279 0.69 (0.38–1.25)
Age
«36 yr 59 249 53 259 1.25 (0.68–2.28)
37–48 yr 69 282 66 239 0.36 (0.18–0.73)
»49 yr 66 252 57 262 0.63 (0.31–1.27)
Level of education
Secondary school 
  or higher
94 156 101 210 0.59 (0.30–1.16)
Primary school or less 100 625 75 549 0.82 (0.52–1.28)
Unknown 0 2 0 1
Age at first sexual inter-
course
»19 yr 142 509 153 596 0.84 (0.55–1.28)
«18 yr 52 273 23 163 0.57 (0.27–1.19)
Unknown 0 1 0 1
Lifetime number of sexual 
partners
1 146 515 156 603 0.75 (0.49–1.14)
»2 48 267 20 157 0.55 (0.24–1.24)
Unknown 0 1 0 0
Condom use
Yes 22 159 33 175 0.83 (0.37–1.87)
No 172 624 143 585 0.67 (0.44–1.02)
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en that we assessed (Table 3). Results were similar
after the exclusion of men from Spain and Colombia
(odds ratio, 0.79; 95 percent confidence interval, 0.47
to 1.33) and after the exclusion of men from the Phil-
ippines (odds ratio, 0.76; 95 percent confidence in-
terval, 0.51 to 1.15).
To minimize confounding as a result of the wom-
en’s having had male partners other than the current
partner, we restricted the analysis to the 1420 men
whose female partner reported having had only one
sexual partner. We also stratified this analysis according
to several variables related to the male partner’s sexual
behavior in order to test the hypothesis that the re-
duction in the risk of cervical cancer would be great-
er among women whose male partners were at high-
er risk for HPV infection. As one measure of risk, we
computed an index based on a man’s age when he first
had sexual intercourse and his total number of sexual
partners. Men who had had six or more sexual partners
and who had first had intercourse before the age of
17 years were considered to be at high risk; men who
had had five or fewer sexual partners and who were at
least 17 years of age when they first had intercourse
were considered to be at low risk; and the remaining
men were classified as being at intermediate risk.
The inverse relation between circumcision and the
risk of cervical cancer was stronger and was signifi-
cant in the case of women whose partners had a high
risk index and who engaged in sexual practices known
to increase the risk of exposure to HPV, such as having
had intercourse before the age of 17 years, having had
six or more sexual partners, and having a history of
contact with prostitutes (Table 4). Tests for an inter-
action between circumcision status and the male part-
*Monogamous women were women who reported having had only one male partner.
†For all analyses the reference group is current stable female partners of uncircumcised men within
the stratum. Models were adjusted for the study location, age of the male and female subjects, male
subjects’ level of education, male subjects’ age at first sexual intercourse, male subjects’ frequency of
genital washing after sex, male subjects’ lifetime number of sexual partners, and female subjects’ age
at first intercourse. CI denotes confidence interval.
‡High-risk men were those who had had six or more sexual partners and who had first had inter-
course before the age of 17 years. Low-risk men were those who had had five or fewer sexual partners
and who were at least 17 years of age when they first had intercourse. The remaining men were clas-
sified as being at intermediate risk.
TABLE 4. RISK OF CERVICAL CANCER IN THE MONOGAMOUS FEMALE PARTNERS 
OF CIRCUMCISED MEN, AS COMPARED WITH THOSE OF UNCIRCUMCISED MEN, 
ACCORDING TO SELECTED CHARACTERISTICS OF THE MEN.*
CHARACTERISTICS
OF THE MEN
MONOGAMOUS WOMEN WITH 
CERVICAL CANCER
MONOGAMOUS 
CONTROL WOMEN
ODDS RATIO
(95% CI)†
CIRCUMCISED 
PARTNER
UNCIR-
CUMCISED
PARTNER
CIRCUMCISED
PARTNER
UNCIR-
CUMCISED
PARTNER
Overall 146 515 156 603 0.75 (0.49–1.14)
Age at first sexual intercourse
»17 yr 121 315 132 424 0.89 (0.56–1.40)
«16 yr 25 199 24 178 0.30 (0.09–1.06)
Unknown 0 1 0 1
Test for interaction P=0.27
Lifetime number of sexual 
partners
1–5 70 127 90 272 1.40 (0.76–2.57)
»6 74 377 65 325 0.42 (0.23–0.79)
Unknown 2 11 1 6
Test for interaction P=0.03
Sexual intercourse with prosti-
tutes
No 66 132 85 237 1.39 (0.70–2.74)
Yes 80 380 71 365 0.53 (0.30–0.94)
Unknown 0 3 0 1
Test for interaction P=0.32
Sexual-behavior risk index‡
Low 66 111 82 255 1.61 (0.86–3.02)
Intermediate 58 213 57 183 0.50 (0.27–0.94)
High 20 179 16 159 0.18 (0.04–0.89)
Unknown 2 12 1 6
Test for interaction P=0.02
Test for trend P<0.05
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ner’s number of sexual partners and between circum-
cision status and the risk index were significant (P=
0.03 and P=0.02, respectively).
DISCUSSION
In our study, male circumcision was associated with
a reduced risk of penile HPV infection in men. We also
found an inverse association between circumcision and
the risk of cervical cancer was significant among wom-
en whose male partners engaged in sexual practices
known to increase the risk of infection with HPV, such
as having had multiple sexual partners.
The assessment of the reliability and validity of self-
reported circumcision status has yielded inconsistent
results,8,28-30 and potential misclassification of circum-
cision status with the use of this method has been a
major concern in previous studies. One strength of our
study is the high rate of accuracy of self-reported cir-
cumcision status. Medical examination of the penis,
performed in 43 percent of the men, confirmed the
self-reported circumcision status in 95 percent of those
examined. Inverse associations with the risks of penile
HPV infection and cervical cancer were similar when
circumcision status was classified according to self-
report or medical examination. Likewise, the exclusion
of subjects who had not undergone a penile examina-
tion (men from Spain and Colombia) did not materi-
ally affect the findings.
A potential concern with respect to our study was
the fact that 65 percent of the circumcised men were
from the Philippines. This result was not unexpected,
since mass circumcision sessions are regularly conduct-
ed by many organizations in that country and most
boys are circumcised before puberty. We performed a
secondary analysis excluding men from this study site
and found that results were virtually unchanged.
Some studies have reported that genital warts
are more common among uncircumcised men than
among circumcised men,4,5,30-33 but other studies have
not confirmed these associations.2,34-37 Epidemiologic
evidence suggests that the absence of circumcision at
birth and the presence of phimosis, poor genital hy-
giene, genital warts, and HPV infection are risk factors
for penile cancer.3,10,11,38,39 Other data have suggested
that the risk of cervical cancer is reduced among the
female partners of circumcised men, but these studies
were limited by the small number of circumcised men
or the low sensitivity of the methods used to detect
HPV DNA.40-42
Little is known about the mechanisms by which
removal of the foreskin may protect against HPV in-
fection. Our data suggest that, even though circum-
cision increases the probability of maintaining good
penile hygiene, there are other ways in which circum-
cision reduces the risk of penile HPV infection.
The penile shaft and the outer surface of the fore-
skin are covered by a keratinized stratified squamous
epithelium that provides a protective barrier against
HPV infection. In contrast, the mucosal lining of
the prepuce is not keratinized and may be more vul-
nerable to the virus.43 Since during intercourse the
foreskin is pulled back, the inner mucosal surface of
the prepuce is wholly exposed to vaginal secretions.
HPV might be afforded access to the basal cells
through minute ulcers or small epithelial abrasions.44
Removal of the foreskin could minimize the probabil-
ity of viral entry by markedly decreasing both the size
of the surface area vulnerable to HPV and the likeli-
hood of mucosal trauma during intercourse. The glans
of a circumcised penis has a thicker, cornified epithe-
lium, making it more resistant to abrasions and less
susceptible to the entry of HPV. The only mucosal
epithelium in a circumcised penis is in the distal ure-
thra, a site known to contain comparatively few HPV-
related lesions.33
Our finding that male circumcision may reduce the
risk of cervical cancer in female sex partners is highly
plausible for several reasons. First, circumcision is as-
sociated with a significant decrease in the risk of penile
HPV infection. Second, and as indicated in further
analyses of the same data, penile HPV infection is as-
sociated with a fourfold increase in the risk of cervical
HPV infection in the female partner (data not shown).
Third, cervical HPV infection is associated with a 77-
fold increase in the risk of cervical cancer (data not
shown).
In conclusion, our study has provided epidemiolog-
ic evidence that male circumcision is associated with
a reduced risk of genital HPV infection in men and
with a reduced risk of cervical cancer in women with
high-risk sexual partners. Thus, circumcision can be
considered an important cofactor in the natural his-
tory of HPV infection, since it may influence the risks
of the acquisition and transmission of HPV as well as
of cervical cancer. These findings are consistent with
those of other studies that male circumcision is asso-
ciated with a reduced risk of HIV infection,7-9 penile
cancer,2,3 and a number of other common sexually
transmitted diseases.4,5 Given the worldwide effect of
these diseases on public health, further study is need-
ed to determine whether routine circumcision can re-
duce the risks of HIV and HPV infections and other
sexually transmitted diseases.
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APPENDIX
The members of the International Agency for Research on Cancer (IARC)
Multicenter Cervical Cancer Study Group are as follows: N. Muñoz, S.
Franceschi, J.S. Smith, M. Plummer, IARC, Lyons, France; F.X. Bosch, S.
de Sanjosé, X. Castellsagué, V. Moreno, Institut Català d’Oncologia, Bar-
celona, Spain; L.C. González, Servicio Territorial de Sanidad y Bienestar So-
cial, Salamanca, Spain; M. Gili, Universidad de Sevilla, Seville, Spain; I.
Izarzugaza, Euskadi Cancer Registry, Vitoria-Gasteiz, Spain; P. Viladiu,
Registre de Càncer de Catalunya, Barcelona, Spain; C. Navarro, Consejería
de Sanidad, Murcia, Spain; A. Vergara, Servicio Provincial de Sanidad,
Zaragoza, Spain; N. Ascunce, Programa de Cáncer de Mama, Pamplona,
Spain; M. Santamaria, Hospital de Navarra, Pamplona, Spain; C.J.L.M.
Meijer, J.M.M. Walboomers, P.J. Snijders, A.J. van den Brule, Free Univer-
sity Hospital, Amsterdam; K.V. Shah, Johns Hopkins University, Baltimore;
R. Herrero, Proyecto Epidemiológico Guanacaste, San José, Costa Rica; L.
Tafur, N. Aristizabal, Universidad de Valle, Cali, Colombia; P. Alonso de
Ruiz, General Hospital of Mexico, Mexico City, Mexico; S. Chichareon, Prince
of Songkla University, Hat-Yai, Thailand; C. Ngelangel, University of the
Philippines, Manila, the Philippines; and J. Eluf-Neto, Universidade de São
Paulo, São Paulo, Brazil.
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